These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15258894)
21. Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. Kaneyuki U; Ueda S; Yamagishi S; Kato S; Fujimura T; Shibata R; Hayashida A; Yoshimura J; Kojiro M; Oshima K; Okuda S Vascul Pharmacol; 2007 Apr; 46(4):286-92. PubMed ID: 17178255 [TBL] [Abstract][Full Text] [Related]
22. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090 [TBL] [Abstract][Full Text] [Related]
23. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity. Smyth SS; Sciorra VA; Sigal YJ; Pamuklar Z; Wang Z; Xu Y; Prestwich GD; Morris AJ J Biol Chem; 2003 Oct; 278(44):43214-23. PubMed ID: 12909631 [TBL] [Abstract][Full Text] [Related]
24. Interaction between platelets and endothelial progenitor cells via LPA-Edg-2 axis is augmented by PPAR-δ activation. Han JK; Kim BK; Won JY; Shin Y; Choi SB; Hwang I; Kang J; Lee HJ; Koh SJ; Lee J; Hur J; Cho HJ; Chae IH; Oh BH; Park YB; Kim HS J Mol Cell Cardiol; 2016 Aug; 97():266-77. PubMed ID: 27266389 [TBL] [Abstract][Full Text] [Related]
26. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. Williams JR; Khandoga AL; Goyal P; Fells JI; Perygin DH; Siess W; Parrill AL; Tigyi G; Fujiwara Y J Biol Chem; 2009 Jun; 284(25):17304-17319. PubMed ID: 19366702 [TBL] [Abstract][Full Text] [Related]
27. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline. Nilsson U; Svensson SP; Grenegård M Haematologica; 2002 Jul; 87(7):730-9; discussion 739. PubMed ID: 12091124 [TBL] [Abstract][Full Text] [Related]
28. Adhesion of human platelets to albumin is synergistically increased by lysophosphatidic acid and adrenaline in a donor-dependent fashion. Eriksson AC; Whiss PA; Nilsson UK Blood Coagul Fibrinolysis; 2006 Jul; 17(5):359-68. PubMed ID: 16788312 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of antiplatelet activity of nifedipine: role of peroxisome proliferator-activated receptor-β-γ-dependent processes. Shih CY; Lin MH; Fan HC; Chen FC; Chou TC J Hypertens; 2014 Jan; 32(1):181-92. PubMed ID: 24126710 [TBL] [Abstract][Full Text] [Related]
30. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Yoshida K; Nishida W; Hayashi K; Ohkawa Y; Ogawa A; Aoki J; Arai H; Sobue K Circulation; 2003 Oct; 108(14):1746-52. PubMed ID: 14504178 [TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases. Gendaszewska-Darmach E Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605 [TBL] [Abstract][Full Text] [Related]
32. Selective non-lipid modulator of LPA5 activity in human platelets. Kozian DH; Evers A; Florian P; Wonerow P; Joho S; Nazare M Bioorg Med Chem Lett; 2012 Aug; 22(16):5239-43. PubMed ID: 22801643 [TBL] [Abstract][Full Text] [Related]
33. Effects of peroxisome proliferator-activated receptor γ in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases. Du H; Hu H; Zheng H; Hao J; Yang J; Cui W Thromb Res; 2014 Jul; 134(1):111-20. PubMed ID: 24856644 [TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Chung SM; Bae ON; Lim KM; Noh JY; Lee MY; Jung YS; Chung JH Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):414-21. PubMed ID: 17110600 [TBL] [Abstract][Full Text] [Related]
35. [Lysophosphatidic acid receptors and the downstream signaling pathways in regulation of cardiac cell growth]. Chen X Sheng Li Xue Bao; 2007 Oct; 59(5):619-27. PubMed ID: 17940702 [TBL] [Abstract][Full Text] [Related]
36. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Bot M; Bot I; Lopez-Vales R; van de Lest CH; Saulnier-Blache JS; Helms JB; David S; van Berkel TJ; Biessen EA Am J Pathol; 2010 Jun; 176(6):3073-84. PubMed ID: 20431029 [TBL] [Abstract][Full Text] [Related]
37. Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome. Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kurano M; Kishimoto T; Yanagisawa N; Ogita M; Miyazaki T; Nishino A; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Daida H; Yatomi Y Atherosclerosis; 2013 Jul; 229(1):192-7. PubMed ID: 23664202 [TBL] [Abstract][Full Text] [Related]